Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Administration and Policy in Mental Health|March 18, 2008
Enhancing the net benefits of disseminating efficacious prevention programs: a note on target efficiency with illustrative examplesDavid S Salkever, Stephen Johnston, Mustafa C Karakus, et al.
Schizophrenia Research|May 18, 2011
Time to discontinuation of first- and second-generation antipsychotic medications in the treatment of schizophreniaJulie Kreyenbuhl, Eric P Slade, Deborah R Medoff, et al.
Health Technology Assessment (Winchester, England)|September 25, 2010
Group cognitive behavioural therapy for postnatal depression: a systematic review of clinical effectiveness, cost-effectiveness and value of information analysesM D Stevenson, A Scope, P A Sutcliffe, et al.
Psychiatric Services (Washington, D.C.)|March 12, 2013
Costs of a public health model to increase receipt of hepatitis-related services for persons with mental illnessEric P Slade, Stanley Rosenberg, Lisa B Dixon, et al.
BMC Psychiatry|January 12, 2010
The cost of relapse and the predictors of relapse in the treatment of schizophreniaHaya Ascher-Svanum, Baojin Zhu, Douglas E Faries, et al.
Applied Neuropsychology|May 26, 2007
Scientific investigation of brain-behavior relationships using the Halstead-Reitan BatteryJames E Sweeney, Heather P Slade, Richard G Ivins, et al.
Cytometry|July 1, 1984
The DNA-based human karyotypeB H Mayall, A V Carrano, D H Moore, et al.
Psychiatric Services (Washington, D.C.)|February 16, 2013
Assertive community treatment in veterans affairs settings: impact on adherence to antipsychotic medicationMarcia Valenstein, John F McCarthy, Dara Ganoczy, et al.
Pageof 15